Cellular Biology |
From the Department of Physiology (P.S., C.P., M.E., E.N.), University of Bern, Bern, Switzerland; the Department of Physiology (P.S.), Medical and Health Science Center, University of Debrecen, Debrecen, Hungary; and the Department of Pharmacology and Cell Biophysics (E.G.K.), University of Cincinnati, Cincinnati, Ohio.
Correspondence to E. Niggli, Dept of Physiology, University of Bern, Buehlplatz 5, CH-3012 Bern, Switzerland. E-mail niggli{at}pyl.unibe.ch
| Abstract |
|---|
|
|
|---|
2-fold. Application of cyclopiazonic acid at moderate concentrations (<10 µmol/L) slowed down recovery from refractoriness in a dose-dependent manner. Compared with cells from wild-type littermates, those from phospholamban knockout (PLB-KO) mice exhibited almost 5-fold accelerated recovery from refractoriness. Our results suggest that SR Ca2+ refilling mediated by the SR Ca2+-pump corresponds to the rate-limiting step for recovery from CICR refractoriness. Thus, the Ca2+ sensitivity of CICR appears to be regulated by SR Ca2+ content, possibly resulting from a change in the steady-state Ca2+ sensitivity and in the gating kinetics of the SR Ca2+ release channels (ryanodine receptors). During Ca2+ release, the concomitant reduction in Ca2+ sensitivity of the ryanodine receptors might also underlie Ca2+ spark termination by deactivation.
Key Words: calcium-induced calcium release excitation-contraction coupling cardiac myocyte heart sarcoplasmic reticulum calcium content photolysis of caged calcium
| Introduction |
|---|
|
|
|---|
The goal of the present study was to examine whether SR Ca2+ content may indeed determine RyR Ca2+ sensitivity and whether SR Ca2+ refilling is the rate-limiting step determining the recovery from refractoriness. For this purpose, we applied pharmacological interventions to correlate SR Ca2+ pump (SERCA) activity with the time course of recovery from refractoriness. To this end, we elicited Ca2+ release from the SR by using UV-laser flash photolysis of caged Ca2+ as the trigger. The resulting Na+-Ca2+ exchange currents (INCX) were analyzed to evaluate SR Ca2+ release events and to characterize the refractoriness of CICR in terms of its temporal features.9 Analogous experiments were also performed in myocytes from phospholamban (PLB)-deficient mice. PLB is a protein, which regulates SR Ca2+ cycling in cardiomyocytes by reversibly inhibiting the SERCA.11 We found that SR Ca2+ refilling is strongly influencing recovery from CICR refractoriness. Thus, the Ca2+ sensitivity of the RyRs appears to be regulated by SR Ca2+ content. Preliminary reports describing this work have been presented in abstract form.12,13
| Materials and Methods |
|---|
|
|
|---|
Electrophysiological Recordings
Cells were voltage-clamped in the whole-cell configuration of the patch-clamp technique and held at 80 mV. The SR was loaded with Ca2+ by six depolarizing steps to 10 mV lasting 200 ms, at 1 Hz, to elicit L-type Ca2+ currents. INCX were recorded at 40 mV to estimate changes in intracellular Ca2+ concentration ([Ca2+]i). Within the [Ca2+]i jumps reached under our conditions, INCX is known to depend linearly on [Ca2+]i.15 The SR Ca2+ content was estimated by integrating the INCX induced by rapid application of 20 mmol/L caffeine. All values are expressed as means±SEM. Student unpaired t tests were used to test for statistical significance (P<0.01, as indicated).
Flash Photolysis
Pairs of UV-light flashes were used to photolyse intracellular DM-nitrophen in an epi-illumination arrangement and were generated with a frequency-tripled neodymium: yttrium-aluminum garnet laser (Nd:YAG laser) (wavelength 355 nm, maximal energy 20.7 mJ, repetition rate up to 10 Hz; Shurelite II; Continuum). Photoconsumption of DM-nitrophen in our setup was determined as
4% at maximum tolerable laser power.
| Results |
|---|
|
|
|---|
ß-Adrenergic Stimulation Accelerates Recovery From Refractoriness
In the following experiments, we used guinea pig ventricular myocytes to record INCX generated by the electrogenic Na+-Ca2+ exchanger, as estimates of changes in the intracellular Ca2+ concentration, [Ca2+]i. INCX has been shown to be linearly dependent on [Ca2+]i over the range of concentrations covered by UV-flash photolysis of caged Ca2+.9,15 Laser-flash photolysis of DM-nitrophen caused a rapid and homogeneous Ca2+ concentration jump (
<30 µs) that resulted in an almost immediate activation of inward INCX.16 The fast photochemical Ca2+ release from DM-nitrophen was reflected in a rapidly rising INCX component, followed by a slower increase in INCX (INCX-slow), continuing for
50 ms before INCX started to decline, in parallel with the decrease in [Ca2+]i. The slow component of INCX activation arises from CICR triggered by the photolytic Ca2+ release, and the amplitude of INCX-slow can be used to estimate the magnitude of CICR (see also inset in Figure 1 Ba).9 Figure 1A shows the loading protocol, which was applied to ensure comparable SR Ca2+ load conditions. In this series of experiments, we applied isoproterenol as an agonist for the ß-adrenergic receptors to accelerate the SERCA. Subsequent to receptor activation, Protein kinase Adependent phosphorylation of PLB is known to relieve the suppression of the SERCA, thereby, accelerating the pump and SR Ca2+ refilling. Thus, we used the SERCA stimulation to test the hypothesis that recovery from CICR refractoriness is governed by SR Ca2+ refilling.
|
Figure 1C compares the results from experiments with pairs of UV-laser flashes in control conditions (left panels) and in the presence of 1 µmol/L isoproterenol (right panels). The concentration of isoproterenol used was
100-fold the EC50 and was chosen to rapidly activate a large fraction of the ß-adrenergic receptors.17 When the interval between successive flashes was longer than
500 ms, INCX exhibited approximately the same peak amplitude, particularly in the presence of ß-adrenergic stimulation (Figure 1C). However, when the interval between photolytic trigger signals was gradually reduced, the second INCX in a pair became progressively smaller in both cases (Figure 1C and 1D). Previous experiments in the presence of ryanodine and thapsigargin have confirmed that the photolytic component and, therefore INCX per se, was not smaller after the second flash.9 (An example is also shown in Figure 1Bb.) The reduction of the slow component of INCX at short intervals thus indicates that the CICR was curtailed and refractory after the second pulse of a pair (see inset, Figure 1B). In control conditions, SR Ca2+ release exhibited refractoriness recovering with a
of 717.9±60.9 ms (Figure 1D). Interestingly, the INCX decayed faster with a
of 162.4±13.8 ms. Even though this time course reflects the decay of [Ca2+]I near the sarcolemma, it allows an, albeit very indirect, estimate of SR refilling. The recovery of CICR was significantly accelerated by isoproterenol treatment (
=342.0±15.8 ms). Although this result is entirely consistent with our hypothesis, unfortunately, ß-adrenoceptor stimulation is thought to alter many cellular processes involved in cardiac Ca2+ signaling, including RyR phosphorylation and changes of steady-state SR Ca2+ content via the intended SERCA stimulation.1821 Both mechanisms could, in principle, lead to modifications of the Ca2+ sensitivity of the RyRs and thus of CICR, which might change the time course of recovery from CICR refractoriness independently of the rate of SR refilling.
Inhibition of the SERCA Slows Recovery From CICR Refractoriness
Because the accelerated recovery from refractoriness after ß-adrenoceptor stimulation could result from several modifications of the Ca2+-signaling machinery, we intended to apply a more specific pharmacological approach to test the hypothesis that SERCA activity governs CICR recovery. To slow down the SERCA several inhibitors are available. Cyclopiazonic acid (CPA), an inhibitor of the SERCA, could be a pharmacological tool to tune its function in a graded fashion.22 In SR vesicles derived from cardiac muscle, CPA inhibits Ca2+ uptake at nanomolar concentrations. In contrast to thapsigargin, the inhibitory effect of CPA is reversible. We applied CPA at low concentrations to slow down, but not completely inhibit, the SERCA. This would be expected to subsequently slow down the recovery from CICR refractoriness, at least when SR Ca2+ refilling via the SERCA was the rate-limiting step. Before carrying out experiments on the recovery from CICR refractoriness, we assessed the steady-state SR Ca2+ content during application of CPA. The voltage-clamp protocol outlined in Figure 1A was applied, and the SR was again loaded Ca2+ by applying a train of six ICa,L. But instead of using UV flashes after the loading protocol, the cells were briefly exposed to 20 mmol/L caffeine to empty the SR. The amount of Ca2+ released by the application of caffeine was estimated by integrating the caffeine-induced INCX recorded at 40 mV. Figure 2A shows the relative SR Ca2+ content after 1 minute application of 1 µmol/L, 5 µmol/L, and 10 µmol/L CPA. The lowest concentration of CPA used is smaller than the IC50 in intact cells and was selected to inhibit just a fraction of the SERCAs. It has been shown previously that this concentration causes
25% decrease in the twitch tension of guinea pig atria.23 In the presence of CPA the SR Ca2+ content decreased in a concentration-dependent manner. The data revealed that these CPA concentrations were sufficient to gradually slow down the SERCA function and subsequently lower the SR Ca2+ content. To verify that we could still release Ca2+ from the SR and thus activate CICR with flash photolytic Ca2+ concentration jumps, we determined the ratio of CICR (INCX-slow) before drug application and in the presence of CPA. Figure 2B shows that SR Ca2+ release could still be elicited photolytically despite a 1 minute exposure to a low concentration of CPA
|
Recovery From CICR Refractoriness in the Presence of CPA
To assess the effect of slowing down (but not completely inhibiting) Ca2+ uptake via the SERCA, we performed refractoriness recovery experiments in the presence of various concentrations of CPA (Figure 3). For this purpose, experiments analogous to those described in Figure 1 were performed, now in the presence of 1 µmol/L and 5 µmol/L CPA. In this series of experiments, CICR recovered with a
of 720.0±31.8 ms in control conditions, and the recovery was slowed down in the presence of 1 µmol/L CPA (
=792.2±23.6 ms). This effect of CPA was concentration dependent, and by increasing CPA to 5 µmol/L, the time constant for recovery was further prolonged to 943.9±34 ms. A CPA concentration of 10 µmol/L almost completely inhibited the SERCA (Figure 3, inset), similar to our previous observations with thapsigargin (not shown). This high CPA concentration thus prevented sufficient refilling of the SR within the time window of our experiments.
|
Effect of Phospholamban on Recovery from CICR Refractoriness in Genetically Modified Mice
Both the acceleration of CICR recovery after ß-adrenergic stimulation and the retardation of recovery during SERCA inhibition are consistent with the notion that SR refilling plays an important role for the time course of recovery from refractoriness. To validate this conclusion we wanted to make use of an approach not entirely relying on pharmacological tools. To this end, we performed refractoriness experiments on myocytes isolated from PLB knockout (PLB-KO) mice and their respective wild-type (WT) littermates. The experiments were analogous to those described in Figures 1 and 3. The left column of Figure 4 (A and B) shows examples of exchange currents elicited by pairs of UV-laser flashes with a shorter (200 ms) and a longer (900 ms) interval recorded in myocytes from WT (Figure 4A) and PLB-KO (Figure 4B) mice. Compared with INCX from WT, the traces recorded from PLB-KO mice showed a more rapid decay, as expected because of the abbreviated Ca2+ transient present in these animals. The application of isoproterenol and CPA in WT mice resulted in changes of the time course of recovery similar to those observed in guinea pigs (Figure 4A: control, 239.5±8.2 ms; isoproterenol, 175.5±7.1 ms; CPA, 531.3±9.4 ms). Compared with WT myocytes, the recovery was accelerated almost 5-fold in PLB-KO cells (Figure 4B). As expected, ß-adrenergic stimulation could not further accelerate the recovery in PLB-KO mice, whereas CPA slowed it down, as in guinea pigs and WT mice (Figure 4B: control, 54.9±3.7 ms; isoproterenol, 54.5±1.9 ms; CPA, 231.5±13.1 ms).
|
| Discussion |
|---|
|
|
|---|
Based on the observed discrepancies between slow global and fast local recovery from CICR refractoriness, we proposed that the SR Ca2+ content may play a regulatory role for the Ca2+ sensitivity of the RyRs. In other words, if Ca2+-induced inactivation (or adaptation) of RyRs would be the dominant mechanism for CICR refractoriness, then it should be seen not only in global but also in localized CICR events. Interestingly, slowly recovering refractoriness was not observed on the level of local Ca2+-release signals. Because both inactivation and adaptation are even functioning on the level of a single RyR channel, they do not require activation of the entire SR network. This conclusion is also supported by our observation of flash-photolytically induced alternans of Ca2+ release.9 This type of alternans implies that the rise of cytosolic Ca2+ concentration alone is insufficient to inactivate the RyRs. Instead, release of Ca2+ from the SR is required to terminate CICR and cause refractoriness. Therefore, we proposed that recovery from CICR refractoriness is determined by the time course of SR Ca2+ refilling subsequent to global Ca2+ release.9 In principle, two scenarios can be imagined how SR Ca2+ refilling could relieve refractoriness: (1) the SR Ca2+ concentration could directly affect the RyR Ca2+ sensitivity and thus the recovery from refractoriness by binding to a specific site within the SR; and (2) additional rate-limiting steps could be required after SR Ca2+ refilling, such as conformational changes of one or more proteins.
In the present study, we successfully distinguished between these two possibilities by examining how luminal SR Ca2+ content can control recovery from CICR refractoriness. When Ca2+ inside the SR exerts its effect on the RyR Ca2+ sensitivity without subsequent rate-limiting steps, modifications of the SERCA activity should result in immediate changes in the rate of recovery from CICR refractoriness, which was observed. Nevertheless, some additional, but not rate-limiting, steps may be required after SR refilling (see below). As expected for an immediate effect, acceleration of the SERCA by isoproterenol hastened the recovery from CICR refractoriness. Unfortunately, ß-adrenergic stimulation is not specific for the SERCA, and this observation could arise from protein kinase Amediated phosphorylation of various proteins other than PLB.1821 To clarify this question, we initially tried to target the SERCA function more specifically with thapsigargin. Unfortunately, SERCA inhibition by thapsigargin led to almost no recovery from refractoriness, probably as a result of an excessive inhibition of the SERCA or a reduction of the SR Ca2+ content below a level critical for CICR.30 However, the use of low and intermediate concentrations of CPA permitted better control over SERCA inhibition. At high concentrations of CPA, the recovery from CICR refractoriness was again minimal and similar to that observed in the presence of thapsigargin. Even the first flash did not trigger a substantial SR Ca2+ release; thus CICR already exhibited a state similar to refractoriness, probably attributable to reduced SR Ca2+ content. This was confirmed by the application of caffeine puffs, which revealed that the SR contained significantly less Ca2+ in presence of high concentrations of CPA. However, at low concentrations of CPA, recovery from CICR refractoriness was slowed down in a dose-dependent manner. In the presence of CPA the recovery from CICR refractoriness remained incomplete, as expected. This may have several reasons: (1) significant photoconsumption of the caged compound which is not replenished from the patch-pipette between two flashes leads to a reduced second INCX; (2) in the presence of CPA, the SR may not refill to the same extent after a flash as during the vigorous SR loading protocol with several Ca2+ currents; or (3) there may be also a slower phase of recovery of some RyRs, which could take several seconds.31
In experiments performed in myocytes obtained from PLB-KO mice, we found an almost 5-fold acceleration of recovery from refractoriness, when compared with WT myocytes. PLB is known to suppress the SERCA, and the ablation of PLB has been described to accelerate SR refilling.11,32 The lack of any further acceleration of recovery from refractoriness by exposure to isoproterenol in PLB-KO mice suggests that SERCA activation and subsequent changes of SR Ca2+ refilling are the dominant effects of ß-adrenergic stimulation under our experimental conditions. However, this observation does not allow for the inference that phosphorylation of proteins other than PLB (eg, the RyRs) has no effect on CICR features other than the amplitude of the transient (eg, on the gating cooperativity or open probability of the RyRs). Based on our results, we conclude that Ca2+ refilling of the SR via the SERCA is a rate-limiting step governing recovery from CICR refractoriness. However, INCX signals reflecting subsarcolemmal [Ca2+]I and, indirectly, SR refilling, decay more rapidly than recovery of CICR occurs. This may reflect subsarcolemmal Ca2+ depletion resulting from the Na+-Ca2+ exchange activity,33 but could also be explained by one or more additional steps required for the recovery of CICR subsequent to SR refilling. Taken together, the most likely explanation for our observations is that CICR refractoriness results from SR Ca2+ depletion during Ca2+ release and that store emptying leads to deactivation and termination of the Ca2+ release by reducing the Ca2+ sensitivity of the RyRs on the cytosolic side of the channels.34 This notion is also supported by recent findings of prolonged Ca2+ spark durations after increasing the buffer capacity and Ca2+ content of the SR, either by adding chemical buffers or by overexpression of calsequestrin.27,35
An important unsolved question is how the EC-coupling machinery can sense the releasable SR Ca2+ content or the free Ca2+ concentration in the SR. In any case, SR Ca2+ contentdependent regulation and termination of CICR requires the presence of Ca2+ sensors inside the SR or on the luminal side of the RyRs. In bilayer experiments, the presence of Ca2+-binding sites on the luminal side of the RyR has been reported36 (but this notion has not remained unchallenged37). Alternatively, this signaling pathway may involve Ca2+ binding to proteins inside the SR, like calsequestrin or other Ca2+-binding proteins. This in turn may induce conformational changes, which are relayed to the RyRs via allosteric interactions and/or via other proteins, such as triadin and junctin.38,39 This finally could lead to a change in the sensitivity of the RyRs for Ca2+.27 In fact, very recently it was shown that by adding calsequestrin, triadin, and junctin to purified RyRs incorporated in lipid bilayers, the dependence of the channels on luminal Ca2+ can be restored.40 In the future, additional studies in intact cells will be required to identify and characterize the signaling pathway that connects local and global SR Ca2+ content with the Ca2+ sensitivity of the RyRs for incoming trigger signals. A detailed understanding of the mechanisms regulating RyR Ca2+ sensitivity is not only a prerequisite for comprehending EC-coupling, but also for appreciating the importance of pathological alterations in EC-coupling during diseases.41 In addition, disruption of the normal function of SR Ca2+ buffering has recently been reported to be causally related to potentially lethal arrhythmias.42
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2. Fabiato A. Time and calcium dependence of activation and inactivation of calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned canine cardiac Purkinje cell. J Gen Physiol. 1985; 85: 247289.
3. Cheng H, Lederer WJ, Cannell MB. Calcium sparkelementary events underlying excitation-contraction coupling in heart muscle. Science. 1993; 262: 740744.
4. Stern MD. Theory of excitation-contraction coupling in cardiac muscle. Biophys J. 1992; 63: 497517.[Medline] [Order article via Infotrieve]
5. Cheng H, Lederer MR, Lederer WJ, Cannell MB. Calcium sparks and [Ca2+] waves in cardiac myocytes. Am J Physiol. 1996; 270: C148C159.[Medline] [Order article via Infotrieve]
6. Sham JS, Song LS, Chen Y, Deng LH, Stern MD, Lakatta EG, Cheng H. Termination of Ca2+ release by a local inactivation of ryanodine receptors in cardiac myocytes. Proc Natl Acad Sci U S A. 1998; 95: 1509615101.
7. Terentyev D, Viatchenko-Karpinski S, Györke I, Terentyeva R, Györke S. Protein phosphatases decrease sarcoplasmic reticulum calcium content by stimulating calcium release in cardiac myocytes. J Physiol. 2003; 552: 109118.
8. Vornanen M, Shepherd N. Restitution of contractility in single ventricular myocytes of guinea pig heart. Cardiovasc Res. 1997; 33: 611622.
9. DelPrincipe F, Egger M, Niggli E. Calcium signalling in cardiac muscle: refractoriness revealed by coherent activation. Nat Cell Biol. 1999; 415: 323329.
10. Niggli E, Lederer WJ. Voltage-independent calcium release in heart muscle. Science. 1990; 250: 565568.
11. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T, Kranias EG. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ Res. 1994; 75: 401409.
12. Szentesi P, Pignier C, Kranias EG, Egger M, Niggli E. SR Ca determines recovery of CICR from refractoriness in cardiac myocytes. J Muscle Res Cell Motil. 2003; 24: 359.
13. Egger M, Szentesi P, Pignier C, Kranias EG, Niggli E. SR Ca2+ controls recovery from refractoriness and termination of CICR in cardiac muscle. Biophys J. 2004; 86: 344a.
14. Niggli E, Lederer WJ. Activation of Na-Ca exchange current by photolysis of caged calcium. Biophys J. 1993; 65: 882891.[Medline] [Order article via Infotrieve]
15. Beuckelmann DJ, Wier WG. Sodium-calcium exchange in guinea-pig cardiac cells: exchange current and changes in intracellular Ca2+. J Physiol. 1989; 414: 499520.
16. Ellis-Davies GCR, Kaplan JH, Barsotti RJ. Laser photolysis of caged calcium: rates of calcium release by nitrophenyl-EGTA and DM-nitrophen. Biophys J. 1996; 70: 10061016.[Medline] [Order article via Infotrieve]
17. Katsube Y, Yokoshuki H, Nguyen L, Sperelakis N. Differences in isoproterenol stimulation of Ca2+ current of rat ventricular myocytes in neonatal compared to adult. Eur J Pharmacol. 1996; 317: 391400.[CrossRef][Medline] [Order article via Infotrieve]
18. Valdivia HH, Kaplan JH, Ellis-Davies GCR, Lederer WJ. Rapid adaptation of cardiac ryanodine receptors: modulation by Mg2+ and phosphorylation. Science. 1995; 31: 19972000.
19. Reiken S, Gaburjakova M, Guatimosim S, Gomez AM, DArmiento J, Burkhoff D, Wang J, Vassort G, Lederer WJ, Marks AR. Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol. J Biol Chem. 2003; 278: 444453.
20. James P, Inui M, Tada M, Chiesi M, Carafoli E. Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum. Nature. 1989; 342: 9092.[CrossRef][Medline] [Order article via Infotrieve]
21. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N, Marks AR. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell. 2000; 101: 365376.[CrossRef][Medline] [Order article via Infotrieve]
22. Seidler NW, Jona I, Vegh M, Martonosi A. Cyclopiazonic acid is a specific inhibitor of the Ca2+-ATPase of sarcoplasmic reticulum. J Biol Chem. 1989; 264: 1781617823.
23. Yard NJ, Chiesi M, Ball HA. Effect of cyclopiazonic acid, an inhibitor of sarcoplasmic reticulum Ca2+-ATPase, on the frequency-dependence of the contraction-relaxation cycle of the guinea-pig isolated atrium. Br J Pharmacol. 1994; 113: 10011007.[Medline] [Order article via Infotrieve]
24. Györke S, Fill M. Ryanodine receptor adaptationcontrol mechanism of Ca2+-induced Ca2+ release in heart. Science. 1993; 260: 807809.
25. Lukyanenko V, Wiesner TF, Györke S. Termination of Ca2+ release during Ca2+ sparks in rat ventricular myocytes. J Physiol. 1998; 507: 667677.
26. Bassani JW, Yuan W, Bers DM. Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes. Am J Physiol. 1995; 268: C1313C1319.[Medline] [Order article via Infotrieve]
27. Terentyev D, Viatchenko-Karpinski S, Györke I, Volpe P, Williams S, Györke S. Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: Mechanism for hereditary arrhythmia. Proc Natl Acad Sci U S A. 2003; 100: 1175911764.
28. Soeller C, Cannell MB. Numerical simulation of local calcium movements during L-type calcium channel gating in the cardiac diad. Biophys J. 1997; 73: 97111.[Medline] [Order article via Infotrieve]
29. Näbauer M, Morad M. Ca2+-induced Ca2+ release as examined by photolysis of caged Ca2+ in single ventricular myocytes. Am J Physiol. 1990; 258: C189C193.[Medline] [Order article via Infotrieve]
30. Shannon T, Ginsburg K, Bers D. Potentiation of fractional sarcoplasmic reticulum calcium release by total and free intra-sarcoplasmic reticulum calcium concentration. Biophys J. 2000; 78: 334343.[Medline] [Order article via Infotrieve]
31. Satoh H, Blatter LA, Bers DM. Effects of [Ca2+]i, SR Ca2+ load, and rest on Ca2+ spark frequency in ventricular myocytes. Am J Physiol. 1997; 272: H657H668.[Medline] [Order article via Infotrieve]
32. Li L, Chu G, Kranias EG, Bers DM. Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMKII effects. Am J Physiol. 1998; 274: H1335H1347.[Medline] [Order article via Infotrieve]
33. Trafford AW, Diaz ME, ONeill SC, Eisner DA. Comparison of subsarcolemmal and bulk calcium concentration during spontaneous calcium release in rat ventricular myocytes. J Physiol. 1995; 488 (Pt 3): 577586.
34. Sobie E, Dilly K, dos Santos Cruz J, Lederer W, Jafri M. Termination of cardiac Ca2+ sparks: an investigative mathematical model of calcium-induced calcium release. Biophys J. 2002; 83: 5978.[Medline] [Order article via Infotrieve]
35. Terentyev D, Viatchenko-Karpinski S, Valdivia HH, Escobar AL, Györke S. Luminal Ca2+ controls termination and refractory behavior of Ca2+-induced Ca2+ release in cardiac myocytes. Circ Res. 2002; 91: 414420.
36. Lukyanenko V, Györke I, Györke S. Regulation of calcium release by calcium inside the sarcoplasmic reticulum in ventricular myocytes. Pflugers Arch. 1996; 432: 10471054.[CrossRef][Medline] [Order article via Infotrieve]
37. Xu L, Meissner G. Regulation of cardiac muscle Ca2+ release channel by sarcoplasmic reticulum lumenal Ca2+. Biophys J. 1998; 75: 23022312.[Medline] [Order article via Infotrieve]
38. Lee JM, Rho SH, Shin DW, Cho C, Park WJ, Eom SH, Ma J, Kim DH. Negatively charged amino acids within the intraluminal loop of ryanodine receptor are involved in the interaction with triadin. J Biol Chem. 2004; 279: 69947000.
39. Guo W, Campbell KP. Association of triadin with the ryanodine receptor and calsequestrin in the lumen of the sarcoplasmic reticulum. J Biol Chem. 1995; 270: 90279030.
40. Györke I, Hester N, Jones LR, Györke S. The Role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. Biophys J. 2004; 86: 21212128.[Medline] [Order article via Infotrieve]
41. Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB, McCune SA, Altschuld RA, Lederer WJ. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science. 1997; 276: 800806.
42. Viatchenko-Karpinski S, Terentyev D, Györke I, Terentyeva R, Volpe P, Priori S, Napolitano C, Nori A, Williams S, Györke S. Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin. Circ Res. 2004; 94: 471477.
This article has been cited by other articles:
![]() |
K. Gusev and E. Niggli Modulation of the Local SR Ca2+ Release by Intracellular Mg2+ in Cardiac Myocytes J. Gen. Physiol., December 1, 2008; 132(6): 721 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jung, A. S. Martins, E. Niggli, and N. Shirokova Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways Cardiovasc Res, March 1, 2008; 77(4): 766 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gyorke and D. Terentyev Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease Cardiovasc Res, January 15, 2008; 77(2): 245 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Livshitz and Y. Rudy Regulation of Ca2+ and electrical alternans in cardiac myocytes: role of CAMKII and repolarizing currents Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2854 - H2866. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. D. J. ter Keurs and P. A. Boyden Calcium and Arrhythmogenesis Physiol Rev, April 1, 2007; 87(2): 457 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Keller, J. P.Y. Kao, M. Egger, and E. Niggli Calcium waves driven by "sensitization" wave-fronts Cardiovasc Res, April 1, 2007; 74(1): 39 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Iyer, R. J. Hajjar, and A. A. Armoundas Mechanisms of Abnormal Calcium Homeostasis in Mutations Responsible for Catecholaminergic Polymorphic Ventricular Tachycardia Circ. Res., February 2, 2007; 100(2): e22 - e31. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Niggli The Cardiac Sarcoplasmic Reticulum: Filled With Ca2+ and Surprises Circ. Res., January 5, 2007; 100(1): 5 - 6. [Full Text] [PDF] |
||||
![]() |
S. Viatchenko-Karpinski, D. Terentyev, L. A. Jenkins, L. O. Lutherer, and S. Gyorke Synergistic interactions between Ca2+ entries through L-type Ca2+ channels and Na+-Ca2+ exchanger in normal and failing rat heart J. Physiol., September 1, 2005; 567(2): 493 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lindegger and E. Niggli Paradoxical SR Ca2+ release in guinea-pig cardiac myocytes after {beta}-adrenergic stimulation revealed by two-photon photolysis of caged Ca2+ J. Physiol., June 15, 2005; 565(3): 801 - 813. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Sobie, L.-S. Song, and W. J. Lederer Local recovery of Ca2+ release in rat ventricular myocytes J. Physiol., June 1, 2005; 565(2): 441 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ouyang, C. Wu, and H. Cheng Ca2+-induced Ca2+ Release in Sensory Neurons: LOW GAIN AMPLIFICATION CONFERS INTRINSIC STABILITY J. Biol. Chem., April 22, 2005; 280(16): 15898 - 15902. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |